Home
/
ClearPoint Neuro, Inc.
/
Financials
/
Quarterly
ClearPoint Neuro, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ClearPoint Neuro, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$8.86M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$9.22M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$8.49M
May 13, 2025
Q3
2025
Sep 30, 2024
$8.12M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$7.86M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$7.64M
May 13, 2025
Q3
2024
Sep 30, 2023
$5.76M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$5.95M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$5.43M
May 7, 2024
Q3
2023
Sep 30, 2022
$5.15M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$5.20M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$5.03M
May 11, 2023
Q3
2021
Sep 30, 2021
$4.57M
Nov 10, 2021
Q2
2022
Jun 30, 2021
$3.41M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$4.03M
May 11, 2022
Q1
2021
Dec 31, 2020
$12.83M
May 11, 2021
Q3
2021
Sep 30, 2020
$3.52M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$2.48M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$3.12M
May 11, 2021
Q3
2020
Sep 30, 2019
$2.93M
Nov 12, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$8.86M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$9.22M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$8.49M
May 13, 2025
Q3
2025
Sep 30, 2024
$8.12M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$7.86M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$7.64M
May 13, 2025
Q3
2024
Sep 30, 2023
$5.76M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$5.95M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$5.43M
May 7, 2024
Q3
2023
Sep 30, 2022
$5.15M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$5.20M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$5.03M
May 11, 2023
Q3
2022
Sep 30, 2021
$4.57M
Nov 8, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.89M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($5.84M)
Aug 12, 2025
Q3
2025
Jun 30, 2025
($5.84M)
Nov 6, 2025
Q2
2025
Mar 31, 2025
($6.03M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($6.03M)
May 13, 2025
Q3
2025
Mar 31, 2025
($6.03M)
Nov 6, 2025
Q3
2025
Sep 30, 2024
($4.97M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($4.41M)
Aug 12, 2025
Q3
2025
Jun 30, 2024
($4.41M)
Nov 6, 2025
Q3
2025
Mar 31, 2024
($4.15M)
Nov 6, 2025
Q2
2025
Mar 31, 2024
($4.15M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($4.15M)
May 13, 2025
Q3
2024
Sep 30, 2023
($4.81M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($7.05M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($7.05M)
Aug 7, 2024
Q3
2024
Mar 31, 2023
($5.61M)
Nov 7, 2024
Q2
2024
Mar 31, 2023
($5.61M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($5.61M)
May 7, 2024
Q3
2023
Sep 30, 2022
($3.79M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($4.30M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.28M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($5.68M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($6.16M)
May 13, 2025
Q3
2025
Sep 30, 2024
($5.16M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($4.72M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($4.22M)
May 13, 2025
Q3
2024
Sep 30, 2023
($4.90M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($7.13M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($5.71M)
May 7, 2024
Q3
2023
Sep 30, 2022
($3.80M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($4.20M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($3.86M)
May 11, 2023
Q3
2022
Sep 30, 2021
($3.80M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($3.41M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($2.18M)
May 11, 2022
Q3
2021
Sep 30, 2020
($1.27M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($1.48M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($1.21M)
May 11, 2021
Q3
2020
Sep 30, 2019
($910.5K)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($1.29M)
Aug 13, 2020